Pfizer reports strong Q4 earnings with the FY23 guidance

Pfizer Inc. (PFE) on Tuesday reported its latest earnings results. The Earnings Highlights are below:▶️ Full-year 2022 revenues of $100.3 展开

Pfizer Inc. (PFE) on Tuesday reported its latest earnings results. The Earnings Highlights are below:

▶️ Full-year 2022 revenues of $100.3 billion, an all-time high for Pfizer, reflecting 30% operational growth.

▶️ Strong fourth-quarter 2022 revenues of $24.3 billion, reflecting 13% operational growth.

▶️ Full-year 2022 reported diluted EPS of $5.47, up 42% year-over-year, and adjusted diluted eps of $6.58, up 62% year-over-year, both of which represent all-time highs for Pfizer.

▶️ Fourth-quarter 2022 reported diluted EPS of $0.87, up 48% year-over-year, and adjusted diluted EPS of $1.14, up 45% year-over-year.

▶️ Provides full-year 2023 revenue guidance of $67.0 to $71.0 billion and adjusted diluted EPS guidance of $3.25 to $3.45.

1. Do you feel satisfied with the latest earnings results?

2. What's your opinion or analysis about the company?

浏览

2.9万

内容

关注

说说看法

热门

HOANG VIET MAI

2023/02/03 02:15

收入

酷

已翻译

2022年第四季度收益中心

Pfizer reports strong Q4 earnings with the FY23 guidance

Wall-Street Call

2023/01/31 20:46

专栏辉瑞股价因第四季度收入下降而下跌，23财年展望显示COVID产品下滑

欢迎点击要关注~~
$辉瑞(PFE.US)$ 在第四季度业绩喜忧参半以及2023年全年展望低于预期之后，周二盘前交易价格走低。
第四季度调整后每股收益同比增长44％，至1.14美元，超出预期，收入增长2％，至242.9亿美元，但未达到分析师的预期。
冠状病毒疫苗，与合作伙伴共同开发 $BioNTech(BNTX.US)$, Comirnaty 直销和联盟收入同比下降了-9％...

已翻译

Pfizer reports strong Q4 earnings with the FY23 guidance

Vais Bargoroth

2023/01/31 08:06

辉瑞（PFE）财报——前路黯淡

辉瑞（PFE）刚刚公布了其2022年第四季度每股收益 1.14 美元，超过了分析师的估计 1.07 美元。他们预订的收入为 100.3 美元这要归功于 Covid 疫苗和抗病毒的销售，这要归功于其中的一半以上。FY2022但是，乐趣到此为止，因为他们预测，随着Covid疫情的缓解以及疫苗需求的暴跌，FY2023 的收入将下降多达33％。
为了从 Covid b 中实现多元化...

已翻译

Pfizer reports strong Q4 earnings with the FY23 guidance

Trading Waltz

2023/01/31 07:14

PFE 收益

-第四季度非公认会计准则每股收益 1.14 美元高于0.10美元。
-收入为美元24.3B (+1.9% Y/Y) 亏损了1亿美元。
2023 年指南：
-修正值为67.0亿美元至710亿美元，而市场普遍预期为742.3亿美元
-调整后的摊薄每股收益为3.25美元至3.45美元，而市场普遍预期为4.38美元
由于今年年初有大量政府供应，COVID-19 产品的收入在 2023 年达到低点后，预计将在 2024 年增长。

已翻译

Pfizer reports strong Q4 earnings with the FY23 guidance

暂时没有更多了，看看其他话题